The cannabis sector has been trending higher and has been coming well off its summer lows. We have been monitoring this trend and are favorable on the recent price movements.
EVIO Inc., (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce that it has received an approval from Health Canada on an amendment of its Dealer License that will expand the product and service offering for EVIO Canada's Keystone Labs in Edmonton effective August 24, 2018.
EVIO Inc. ("EVIO" or the "Company"), (OTCQB: EVIO), a leading North American provider of cannabis testing and scientific research for the regulated cannabis industry, announced today it has executed a long-term lease for a 2,700 square foot facility in Los Angeles, California to provide its accredited analytical testing services to the Southern California cannabis market.
The cannabis sector has been under pressure and this pullback has created a great opportunity for cannabis investors. When you look back to the same time period last year, it looks likes cannabis stocks are following a similar trend and we are closely monitoring the recent weakness.
Although cannabis growers and distributors have attracted billions worth of capital from investors, there is significant opportunity on the ancillary side of the industry.
EVIO, Inc., (OTCQB: EVIO) a leading cannabis testing company, is on track to double its number of cannabis testing laboratories in 2018, according to management.
EVIO, Inc. (OTCQB:EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, announced today that its Florida Licensee, Kaycha Holdings LLC d/b/a EVIO Labs Florida has attained ISO 17025 accreditation and becomes the first accredited cannabis testing lab in the state.